1. Home
  2. Browse
  3. Bone & Joint
  4. Rheumatoid Arthritis
  5. Drug Toxicity

Drug Toxicity

1 - 15 of 16 Results
Sort Results:
Article: Consider Kidney Risks Before Suggesting an NSAID October 2022
Article: Help Patients Stick With Methotrexate for Rheumatoid Arthritis August 2021
Article: Stay Alert for Safety Issues With Janus Kinase Inhibitors (Xeljanz, etc) October 2019
Article: Expect to See Subcutaneous Methotrexate for Rheumatoid Arthritis April 2018
Article: Recommend Limiting Dose and Duration of NSAIDs in High-CV-Risk Patients January 2017
Article: Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds June 2016
Article: Recommend Folic Acid for Rheumatoid Arthritis Patients on Methotrexate October 2014
Article: Recent warnings about acetaminophen will bring up more questions about serious drug-induced skin reactions October 2013
Article: new ORAL agent for rheumatoid arthritis, Xeljanz (ZEL-jans, tofacitinib) January 2013
Article: PPIs with methotrexate can lead to methotrexate toxicity December 2012
Article: Aggressive management of rheumatoid arthritis often means monitoring multiple meds July 2012
Article: new IV biologic for rheumatoid arthritis called Actemra (ack-TEM-rah) March 2010
Article: limiting the use of piroxicam (Feldene, etc) August 2009
Article: Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis June 2009
Article: stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy December 2007